The Veteran's BPH was granted a rating of 40 percent prior to July 13, 2023, and a 60 percent rating on and after that date. The effective date for the 60 percent rating is set at July 13, 2023.
The deciding factor: The Veteran's BPH was shown to be predominantly manifested by voiding dysfunction with urinary frequency of less than one hour intervals, waking to void four times a night, and leakage requiring changing of absorbent materials two to four times per day on and after July 13, 2023. The maximum schedular rating for this condition is 60 percent.
- Claimed conditions
- Benign prostatic hyperplasia
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 40%
- Decision date
- September 9, 2024
- Citation
- A24053886
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A24053886.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Veteran's claims for increased rating of hypertension and service connection for genitourinary disability, including benign prostatic hyperplasia and urinary incontinence, as secondary to medication used for a service-connected hypertension disability are remanded due to duty to assist errors.
- Denied
The Veteran's service-connected conditions do not meet the criteria for special monthly compensation based on the need of regular aid and attendance due to his psychiatric symptoms.
- Remanded (sent back)
The Veteran's claim for a higher disability rating for bladder cancer is being remanded due to duty-to-assist errors and the need to obtain additional medical records.
- Partly granted
The Board granted service connection for ischemic heart disease and diabetes mellitus type II, both presumed to be related to exposure to herbicides during ACDUTRA at Fort McClellan. The claims for benign prostatic hyperplasia, headaches, and skin cancer were remanded.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.